vs
Side-by-side financial comparison of FIRST COMMONWEALTH FINANCIAL CORP (FCF) and HARROW, INC. (HROW). Click either name above to swap in a different company.
FIRST COMMONWEALTH FINANCIAL CORP is the larger business by last-quarter revenue ($133.7M vs $89.1M, roughly 1.5× HARROW, INC.). FIRST COMMONWEALTH FINANCIAL CORP runs the higher net margin — 28.1% vs 7.4%, a 20.6% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 13.0%). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 5.5%).
First Commonwealth Financial Corp is a Pennsylvania-based regional financial services holding company. It offers consumer and commercial banking products, loans, wealth management, and insurance services for individuals, small and mid-sized enterprises across central and western Pennsylvania and Ohio.
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
FCF vs HROW — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $133.7M | $89.1M |
| Net Profit | $37.5M | $6.6M |
| Gross Margin | — | 79.3% |
| Operating Margin | — | 17.5% |
| Net Margin | 28.1% | 7.4% |
| Revenue YoY | 13.0% | 33.3% |
| Net Profit YoY | 14.8% | -2.2% |
| EPS (diluted) | $0.37 | $0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $133.7M | — | ||
| Q4 25 | $137.9M | $89.1M | ||
| Q3 25 | $136.0M | $71.6M | ||
| Q2 25 | $131.0M | $63.7M | ||
| Q1 25 | $118.0M | $47.8M | ||
| Q4 24 | $120.4M | $66.8M | ||
| Q3 24 | $121.2M | $49.3M | ||
| Q2 24 | $120.2M | $48.9M |
| Q1 26 | $37.5M | — | ||
| Q4 25 | $44.9M | $6.6M | ||
| Q3 25 | $41.3M | $1.0M | ||
| Q2 25 | $33.4M | $5.0M | ||
| Q1 25 | $32.7M | $-17.8M | ||
| Q4 24 | $35.8M | $6.8M | ||
| Q3 24 | $32.1M | $-4.2M | ||
| Q2 24 | $37.1M | $-6.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 79.3% | ||
| Q3 25 | — | 75.3% | ||
| Q2 25 | — | 74.5% | ||
| Q1 25 | — | 67.5% | ||
| Q4 24 | — | 78.8% | ||
| Q3 24 | — | 75.6% | ||
| Q2 24 | — | 74.4% |
| Q1 26 | — | — | ||
| Q4 25 | 40.9% | 17.5% | ||
| Q3 25 | 38.1% | 20.6% | ||
| Q2 25 | 32.1% | 17.9% | ||
| Q1 25 | 34.8% | -23.5% | ||
| Q4 24 | 37.1% | 19.3% | ||
| Q3 24 | 33.4% | 2.7% | ||
| Q2 24 | 38.7% | 3.1% |
| Q1 26 | 28.1% | — | ||
| Q4 25 | 32.5% | 7.4% | ||
| Q3 25 | 30.4% | 1.4% | ||
| Q2 25 | 25.5% | 7.8% | ||
| Q1 25 | 27.7% | -37.2% | ||
| Q4 24 | 29.8% | 10.1% | ||
| Q3 24 | 26.5% | -8.6% | ||
| Q2 24 | 30.9% | -13.2% |
| Q1 26 | $0.37 | — | ||
| Q4 25 | $0.44 | $0.20 | ||
| Q3 25 | $0.39 | $0.03 | ||
| Q2 25 | $0.32 | $0.13 | ||
| Q1 25 | $0.32 | $-0.50 | ||
| Q4 24 | $0.35 | $0.19 | ||
| Q3 24 | $0.31 | $-0.12 | ||
| Q2 24 | $0.36 | $-0.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $72.9M |
| Total DebtLower is stronger | $154.9M | $250.0M |
| Stockholders' EquityBook value | $1.6B | $52.4M |
| Total Assets | $12.3B | $399.5M |
| Debt / EquityLower = less leverage | 0.10× | 4.77× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $72.9M | ||
| Q3 25 | — | $74.3M | ||
| Q2 25 | — | $53.0M | ||
| Q1 25 | — | $66.7M | ||
| Q4 24 | — | $47.2M | ||
| Q3 24 | — | $72.6M | ||
| Q2 24 | — | $71.0M |
| Q1 26 | $154.9M | — | ||
| Q4 25 | $261.7M | $250.0M | ||
| Q3 25 | $262.1M | $347.2M | ||
| Q2 25 | $262.4M | $250.6M | ||
| Q1 25 | $262.7M | $256.9M | ||
| Q4 24 | $263.0M | $262.7M | ||
| Q3 24 | $136.3M | $230.7M | ||
| Q2 24 | $136.6M | $236.3M |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $52.4M | ||
| Q3 25 | $1.5B | $47.0M | ||
| Q2 25 | $1.5B | $49.7M | ||
| Q1 25 | $1.4B | $56.5M | ||
| Q4 24 | $1.4B | $69.7M | ||
| Q3 24 | $1.4B | $58.0M | ||
| Q2 24 | $1.4B | $58.5M |
| Q1 26 | $12.3B | — | ||
| Q4 25 | $12.3B | $399.5M | ||
| Q3 25 | $12.3B | $363.1M | ||
| Q2 25 | $12.2B | $345.0M | ||
| Q1 25 | $11.8B | $364.2M | ||
| Q4 24 | $11.6B | $389.0M | ||
| Q3 24 | $12.0B | $351.5M | ||
| Q2 24 | $11.6B | $306.6M |
| Q1 26 | 0.10× | — | ||
| Q4 25 | 0.17× | 4.77× | ||
| Q3 25 | 0.17× | 7.39× | ||
| Q2 25 | 0.17× | 5.05× | ||
| Q1 25 | 0.18× | 4.55× | ||
| Q4 24 | 0.19× | 3.77× | ||
| Q3 24 | 0.10× | 3.98× | ||
| Q2 24 | 0.10× | 4.04× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | — | $8.4M |
| Free Cash FlowOCF − Capex | — | $8.1M |
| FCF MarginFCF / Revenue | — | 9.1% |
| Capex IntensityCapex / Revenue | — | 0.4% |
| Cash ConversionOCF / Net Profit | — | 1.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $43.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $187.5M | $8.4M | ||
| Q3 25 | $49.5M | $16.6M | ||
| Q2 25 | $30.4M | $-803.0K | ||
| Q1 25 | $55.9M | $19.7M | ||
| Q4 24 | $129.5M | $-17.8M | ||
| Q3 24 | $53.6M | $3.0M | ||
| Q2 24 | $22.7M | $-2.7M |
| Q1 26 | — | — | ||
| Q4 25 | $171.5M | $8.1M | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | — | $-969.0K | ||
| Q1 25 | — | $19.5M | ||
| Q4 24 | $113.9M | $-18.3M | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | — | $-3.1M |
| Q1 26 | — | — | ||
| Q4 25 | 124.3% | 9.1% | ||
| Q3 25 | — | 22.9% | ||
| Q2 25 | — | -1.5% | ||
| Q1 25 | — | 40.8% | ||
| Q4 24 | 94.6% | -27.4% | ||
| Q3 24 | — | 4.8% | ||
| Q2 24 | — | -6.3% |
| Q1 26 | — | — | ||
| Q4 25 | 11.7% | 0.4% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | 12.9% | 0.8% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | 4.18× | 1.27× | ||
| Q3 25 | 1.20× | 16.26× | ||
| Q2 25 | 0.91× | -0.16× | ||
| Q1 25 | 1.71× | — | ||
| Q4 24 | 3.61× | -2.62× | ||
| Q3 24 | 1.67× | — | ||
| Q2 24 | 0.61× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.